Story thread · 5 reports / 4 sources
Key deals this week: Flex, Nvidia, AbbVie and more
seekingalpha.com · 9d
First report: AbbVie succeeds in late-stage trial for multiple myeloma drug — seekingalpha.com, 11d
The coverage
- AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
finance.yahoo.com · 10d
- Trailing rivals, AbbVie scores win with dual-acting myeloma drug
biopharmadive.com · 10d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.